136 related articles for article (PubMed ID: 9095573)
1. [Evaluation of bone and soft tissue lesion using 99mTc-MIBI: comparison with 201Tl and the relation to chemotherapeutic effect].
Sumiya H; Taki J; Tonami N; Asada N; Tsuchiya H; Tomita K
Kaku Igaku; 1997 Feb; 34(2):105-11. PubMed ID: 9095573
[TBL] [Abstract][Full Text] [Related]
2. Evaluating benign and malignant bone and soft-tissue lesions with technetium-99m-MIBI scintigraphy.
Taki J; Sumiya H; Tsuchiya H; Tomita K; Nonomura A; Tonami N
J Nucl Med; 1997 Apr; 38(4):501-6. PubMed ID: 9098190
[TBL] [Abstract][Full Text] [Related]
3. Prediction of final tumor response to preoperative chemotherapy by Tc-99m MIBI imaging at the middle of chemotherapy in malignant bone and soft tissue tumors: comparison with Tl-201 imaging.
Taki J; Higuchi T; Sumiya H; Tsuchiya H; Minato H; Tomita K; Tonami N
J Orthop Res; 2008 Mar; 26(3):411-8. PubMed ID: 17960652
[TBL] [Abstract][Full Text] [Related]
4. Assessment of P-glycoprotein in patients with malignant bone and soft-tissue tumors using technetium-99m-MIBI scintigraphy.
Taki J; Sumiya H; Asada N; Ueda Y; Tsuchiya H; Tonami N
J Nucl Med; 1998 Jul; 39(7):1179-84. PubMed ID: 9669390
[TBL] [Abstract][Full Text] [Related]
5. 99mTc-MIBI in the assessment of response to chemotherapy and detection of recurrences in bone and soft tissue tumours of the extremities.
Moustafa H; Riad R; Omar W; Zaher A; Ebied E
Q J Nucl Med; 2003 Mar; 47(1):51-7. PubMed ID: 12714955
[TBL] [Abstract][Full Text] [Related]
6. Comparison of 99mTc(V)-DMSA, 201Tl and 99mTc-MIBI imaging in the follow-up of patients with medullary carcinoma of the thyroid.
Ugur O; Kostakğlu L; Güler N; Caner B; Uysal U; Elahi N; Haliloğlu M; Yüksel D; Aras T; Bayhan H; Bekdik C
Eur J Nucl Med; 1996 Oct; 23(10):1367-71. PubMed ID: 8781142
[TBL] [Abstract][Full Text] [Related]
7. [201Tl scintigraphic evaluation of tumor mass and viability of bone and soft-tissue tumors].
Tsuda T; Kubota M; Yoshida S; Shibata M; Wakabayashi J; Obata H; Matsuyama T; Usui M; Ishii S
Kaku Igaku; 1994 Dec; 31(12):1477-94. PubMed ID: 7861647
[TBL] [Abstract][Full Text] [Related]
8. Correlation of 99mTc-sestamibi uptake with blood-pool and osseous phase 99mTc-MDP uptake in malignant bone and soft-tissue tumours.
Ozcan Z; Burak Z; Erinç R; Dirlik A; Başdemir G; Sabah D; Ozkiliç H
Nucl Med Commun; 2001 Jun; 22(6):679-83. PubMed ID: 11403180
[TBL] [Abstract][Full Text] [Related]
9. A comparative study of 201Tl scintigraphy and three-phase bone scintigraphy following therapy in patients with bone and soft-tissue tumors.
Nishiyama Y; Yamamoto Y; Yokoe K; Kawaguchi Y; Toyama Y; Satoh K; Ohkawa M
Ann Nucl Med; 2004 May; 18(3):235-41. PubMed ID: 15233285
[TBL] [Abstract][Full Text] [Related]
10. [Comparative evaluation of 99mTc-MIBI (hexakis2-methoxy isobutyl isonitrile) and 201Tl-chloride in primary lung cancer].
Yamamoto Y; Kawasaki Y; Nishiyama Y; Fukunaga K; Satoh K; Takashima H; Ohkawa M; Kumazawa Y; Fujita J; Tanabe M
Kaku Igaku; 1996 May; 33(5):501-11. PubMed ID: 8699618
[TBL] [Abstract][Full Text] [Related]
11. The role of 99mTc-MIBI scintigraphy in the assessment of MDR1 overexpression in patients with musculoskeletal sarcomas: comparison with therapy response.
Burak Z; Ersoy O; Moretti JL; Erinç R; Ozcan Z; Dirlik A; Sabah D; Basdemir G
Eur J Nucl Med; 2001 Sep; 28(9):1341-50. PubMed ID: 11585293
[TBL] [Abstract][Full Text] [Related]
12. Technetium-99m-MIBI and thallium-201 scintigraphy of primary lung cancer.
Nishiyama Y; Kawasaki Y; Yamamoto Y; Fukunaga K; Satoh K; Takashima H; Ohkawa M; Tanabe M
J Nucl Med; 1997 Sep; 38(9):1358-61. PubMed ID: 9293787
[TBL] [Abstract][Full Text] [Related]
13. Uptake of 99mTc-tetrofosmin, 99mTc-MIBI and 201Tl in malignant thymoma.
Hashimoto T; Goto K; Hishinuma Y; Yachuda K; Sugioka Y; Arai K; Harada S; Goto M
Ann Nucl Med; 2000 Aug; 14(4):293-8. PubMed ID: 11023030
[TBL] [Abstract][Full Text] [Related]
14. Thallium-201 scintigraphy in bone and soft-tissue tumors: a comparison of dynamic, early and delayed scans.
Sugawara Y; Kikuchi T; Kajihara M; Semba T; Ochi T; Fujii T; Mochizuki T; Sakayama K; Nakata S
Ann Nucl Med; 2005 Sep; 19(6):461-8. PubMed ID: 16248382
[TBL] [Abstract][Full Text] [Related]
15. [A comparison of 201Tl and 99mTc-MIBI in the follow-up of differentiated thyroid carcinomas].
Briele B; Hotze A; Kropp J; Bockisch A; Overbeck B; Grünwald F; Kaiser W; Biersack HJ
Nuklearmedizin; 1991 Aug; 30(4):115-24. PubMed ID: 1788076
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of thallium-201 scintigraphy in bone and soft tissue tumors.
Goto Y; Ihara K; Kawauchi S; Ohi R; Sasaki K; Kawai S
J Orthop Sci; 2002; 7(3):304-12. PubMed ID: 12077654
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of technetium-99m-MIBI scintigraphy in metastatic differentiated thyroid cancer--comparison study with 131I and 201Tl].
Nagamachi S; Jinnouchi S; Nishii R; Flores LG; Nakahara H; Futami S; Tamura S; Toshimori H; Kawai K
Kaku Igaku; 2000 Mar; 37(2):89-98. PubMed ID: 10783567
[TBL] [Abstract][Full Text] [Related]
18. Limitations of craniocaudal thallium-201 and technetium-99m-sestamibi mammoscintigraphy.
Maurer AH; Caroline DF; Jadali FJ; Manzone TA; Maier WP; Au FC; Schnall SF
J Nucl Med; 1995 Sep; 36(9):1696-700. PubMed ID: 7658233
[TBL] [Abstract][Full Text] [Related]
19. Correlation of technetium-99m MIBI and thallium-201 retention in solitary cold thyroid nodules with postoperative histopathology.
Erdil TY; Ozker K; Kabasakal L; Kanmaz B; Sönmezoglu K; Atasoy KC; Turoglu HT; Uslu I; Isitman AT; Onsel C
Eur J Nucl Med; 2000 Jun; 27(6):713-20. PubMed ID: 10901459
[TBL] [Abstract][Full Text] [Related]
20. Left ventricular dysfunction in coronary artery disease: comparison between rest-redistribution thallium 201 and resting technetium 99m methoxyisobutyl isonitrile cardiac imaging.
Maurea S; Cuocolo A; Pace L; Nicolai E; Nappi A; Imbriaco M; Trimarco B; Salvatore M
J Nucl Cardiol; 1994; 1(1):65-71. PubMed ID: 9420672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]